The purpose of this study is to evaluate ethanol-induced symptoms and safety in breast cancer patients with neoadjuvant/adjuvant chemotherapy including Non-ethanol formulation docetaxel before and after surgery
Study Type
OBSERVATIONAL
Enrollment
1,052
Chung-Ang University Hospital
Seoul, South Korea
RECRUITINGUijeongbu Eulji Medical Center, Eulji University
Uijeongbu-si, South Korea
NOT_YET_RECRUITINGIncidence of ethanol-induced symptoms in the initial cycle
This outcome's definition is an increase from baseline in the number of ethanol-induced symptoms during or within 30 minutes after the treatment. The initial cycle of non-ethanol formulation docetaxel is collected as 1 cycle.
Time frame: From the time of treatment started until the end of follow-up(30 minutes after the treatment)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.